이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Carl Zeiss Meditec 관리
관리 기준 확인 4/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Markus Weber
최고 경영자
€1.1m
총 보상
| CEO 급여 비율 | 40.5% |
| CEO 임기 | 2.8yrs |
| CEO 소유권 | n/a |
| 경영진 평균 재임 기간 | 4.5yrs |
| 이사회 평균 재임 기간 | 3.4yrs |
최근 관리 업데이트
Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being
May 21
How Should Investors Feel About Carl Zeiss Meditec's (ETR:AFX) CEO Remuneration?
Feb 16
Recent updates
Some Investors May Be Worried About Carl Zeiss Meditec's (ETR:AFX) Returns On Capital
Sep 19Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?
Sep 06Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 27%?
Aug 23At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?
Aug 09Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
Jul 11Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled
Jun 10Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing
May 26Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
May 11Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
May 09Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?
Mar 24Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?
Mar 11Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement
Feb 12Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
Jan 29What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?
Dec 08Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital
Nov 08Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price
Oct 24Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?
Sep 24Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?
Sep 08Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
Jul 24We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)
Jun 19Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?
Jun 06Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?
May 22Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price
Apr 19Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet
Feb 26Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 10Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching
Jan 28Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10
Jan 12Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10
Dec 29Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10
Dec 14What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?
Nov 04Calculating The Intrinsic Value Of Carl Zeiss Meditec AG (ETR:AFX)
Oct 18Investors Will Want Carl Zeiss Meditec's (ETR:AFX) Growth In ROCE To Persist
Sep 12Carl Zeiss Meditec (ETR:AFX) Seems To Use Debt Rather Sparingly
Aug 25Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Hit The Brakes
May 30Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?
Feb 27Carl Zeiss Meditec's (ETR:AFX) Returns Have Hit A Wall
Feb 08Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching
Dec 12Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger
Nov 06If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late
Sep 06Investors Met With Slowing Returns on Capital At Carl Zeiss Meditec (ETR:AFX)
Aug 08Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being
May 21Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems
May 18Capital Allocation Trends At Carl Zeiss Meditec (ETR:AFX) Aren't Ideal
Apr 28Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 19% Below Its Share Price
Mar 09How Should Investors Feel About Carl Zeiss Meditec's (ETR:AFX) CEO Remuneration?
Feb 16CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | €203m |
| Mar 31 2024 | n/a | n/a | €261m |
| Dec 31 2023 | n/a | n/a | €277m |
| Sep 30 2023 | €1m | €426k | €290m |
| Jun 30 2023 | n/a | n/a | €308m |
| Mar 31 2023 | n/a | n/a | €278m |
| Dec 31 2022 | n/a | n/a | €307m |
| Sep 30 2022 | €1m | €298k | €294m |
보상 대 시장: Markus 의 총 보상 ($USD 1.16M ) German 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 3.45M ).
보상과 수익: Markus 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Markus Weber
2.8yrs
테뉴어
€1,050,400
보상
Dr. Markus Weber is CEO & Chairman of Management Board of Carl Zeiss Meditec AG from January 01, 2022 and served as its President since January 01, 2022 until December 2022. He joined ZEISS Semiconductor M...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Chairman of Management Board | 2.8yrs | €1.05m | 데이터 없음 | |
| CFO & Member of the Management Board | 6yrs | €799.30k | 데이터 없음 | |
| Head of Global Regulatory & Clinical Affairs | 1.8yrs | 데이터 없음 | 데이터 없음 | |
| Chief Operating Officer | no data | 데이터 없음 | 데이터 없음 | |
| Director of Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Chief Human Resources Officer | no data | 데이터 없음 | 데이터 없음 | |
| Chief Medical Officer for Global Ophthalmic Devices | 8yrs | 데이터 없음 | 데이터 없음 | |
| Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec | 4.6yrs | 데이터 없음 | 데이터 없음 | |
| President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit | 4.4yrs | 데이터 없음 | 데이터 없음 | |
| Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology | no data | 데이터 없음 | 데이터 없음 |
4.5yrs
평균 재임 기간
59yo
평균 연령
경험이 풍부한 관리: AFX 의 관리팀은 경험 ( 4.3 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Head of Global Regulatory & Clinical Affairs | 1.6yrs | 데이터 없음 | 데이터 없음 | |
| Chairman of the Supervisory Board | 4.3yrs | 데이터 없음 | 데이터 없음 | |
| Honorary Chairman of the Supervisory Board | 3.4yrs | €43.10k | 데이터 없음 | |
| Member of the Supervisory Board | 4.3yrs | €36.00k | 데이터 없음 | |
| Member of the Supervisory Board | 3.4yrs | €55.00k | 데이터 없음 | |
| Employee Representative Member of the Supervisory Board | 1.6yrs | 데이터 없음 | 데이터 없음 | |
| Member of the Supervisory Board | 6.5yrs | €52.00k | 데이터 없음 | |
| Employee Representative Deputy Chairman of Supervisory Board | 5yrs | €40.50k | 데이터 없음 | |
| Employee Representative Member of Supervisory Board | 4.6yrs | €36.00k | 데이터 없음 | |
| Member of Supervisory Board | 3.4yrs | 데이터 없음 | 데이터 없음 | |
| Employee Representative Member of the Supervisory Board | 2.6yrs | €19.20k | 데이터 없음 | |
| Employee Representative Member of the Supervisory Board | 1.6yrs | 데이터 없음 | 데이터 없음 |
3.4yrs
평균 재임 기간
53yo
평균 연령
경험이 풍부한 이사회: AFX 의 이사회는 경험(평균 재직 기간 3.3 년)으로 간주됩니다.